An Observational Study of Smoflipid vs Intralipid on the Evolution of Intestinal Failure-Associated Liver Disease in Infants With Intestinal Failure.

CONCLUSION: Use of SMOFlipid resulted in decreased development of IF-associated liver disease in patients with IF when assessed using biochemical tests.
PMID: 31448447 [PubMed - as supplied by publisher]

Source: JPEN Journal Of Parenteral And Enteral Nutrition - August 24, 2019 Category: Nutrition Authors: Belza C, Wales JC, Courtney-Martin G, de Silva N, Avitzur Y, Wales PW Tags: JPEN J Parenter Enteral Nutr Source Type: research